Seattle’s Benaroya Research Institute (BRI) has landed $17.1 million in funding to assess why respiratory infections hit some people particularly hard, to explore new ways of treating type 1 diabetes,… Read More
With 70% of Washington residents age 16 and older having initiated their COVID-19 vaccine, the pandemic can feel, locally at least, like its grip on our lives has loosened. But… Read More
A team including researchers from Seattle’s Benaroya Research Institute at Virginia Mason has identified a new pathway for protecting cells from deadly viruses — including the coronavirus that causes COVID-19… Read More
As part of the scientific community trying to understand the varied and curious symptoms caused by COVID-19, the Benaroya Research Institute (BRI) at Virginia Mason announced Tuesday that it has… Read More
Millions of people around the world suffer from food allergies, but we still know very little about how those allergies develop and how we can prevent or treat them. A… Read More
Caroline Stefani has a cool job: She works at the Benaroya Research Institute at Virginia Mason in Seattle, looking for new ways to treat diseases like multiple sclerosis and Type 1… Read More
Anyone with allergies can tell you how miserable they can be. From annoying seasonal sniffles to life-threatening food allergies, they affect an estimated 50 million people in the U.S. alone,… Read More
For those with allergies and asthma, one small particle can mean hours of wheezing, sneezing, and runny eyes and noses. About a quarter of Americans suffer from allergies, asthma, or both, but we… Read More